Skip to main content
Clinical Trials/ITMCTR2200006865
ITMCTR2200006865Not yet recruitingPhase 1

Clinical study on feibi granule in treating patients with coal worker's pneumoconiosis in remission stage

Fangshan Hospital, Beijing University of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • (1)The coal workers' pneumoconiosis patients of stage I, II and III diagnosed by the occupational disease appraisal institution
  • (2)Meeting the criteria for the remission period
  • (3)It is in accordance with the diagnostic standard of syndrome of deficiency of lung-qi and obstruction of collaterals by phlegm and blood stasis
  • (4)Older than 18 years
  • (5)Agree to participate in the study and sign the informed consent.

Exclusion Criteria

  • (1)Patients report being pregnant/lactating
  • (2)Patients report with mental illness
  • (3)Patients report that they are complicated with respiratory failure, cor pulmonale, pulmonary-cerebral syndrome and severe pulmonary infection
  • (4)Patients with other diseases need to take other traditional Chinese medicine preparations for more than 4 weeks
  • (5)Patients report being enrolled in other clinical trials
  • (6)Patients report allergic constitution or drug allergy to the subject.

Investigators

Sponsor
Fangshan Hospital, Beijing University of Chinese Medicine

Similar Trials